The Rapidly Shifting Ketamine Landscape in the US-Reference-Cited by-同舟云学术

The Rapidly Shifting Ketamine Landscape in the US

Published:2024-03-01 Issue:3 Volume:81 Page:221
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Wilkinson Samuel T.¹²,Palamar Joseph J.³,Sanacora Gerard¹²

Affiliation:

1. Yale Depression Research Program, Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut

2. Interventional Psychiatry Service, Yale–New Haven Hospital, New Haven, Connecticut

3. Department of Population Health, New York University Grossman School of Medicine, New York, New York

Abstract

This Viewpoint discusses changes in the use of ketamine as a medical therapeutic and a recreational substance, the potential risks of use, and the need for increased research and surveillance.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2813622/jamapsychiatry_wilkinson_2024_vp_230042_1709150818.10881.pdf

Reference9 articles.

1. Esketamine for treatment-resistant depression—first FDA-approved antidepressant in a new class.;Kim;N Engl J Med,2019

2. A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders.;Wilkinson;Am J Psychiatry,2017

3. An update on community ketamine practices.;O’Brien;Am J Psychiatry,2022

4. A consensus statement on the use of ketamine in the treatment of mood disorders.;Sanacora;JAMA Psychiatry,2017

5. Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial.;Abbar;BMJ,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse exists;Journal of Affective Disorders;2024-10

2. New Territory: Ethical Challenges Associated With MDMA-Assisted Psychotherapy for PTSD;American Journal of Psychiatry Residents' Journal;2024-09-06

3. At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data;Journal of Affective Disorders;2024-09

4. Ketamine and Esketamine for Depression in Daily Practice;Journal of Clinical Psychopharmacology;2024-08-22

5. State Cannabis and Psychedelic Legislation and Microdosing Interest in the US;JAMA Health Forum;2024-06-28